Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 8 May 2009:
Vol. 324. no. 5928, p. 815
DOI: 10.1126/science.324_815
Prev | Table of Contents | Next

From the AAAS Office of Publishing and Member Services

Business Office Feature:

Life Science Technologies: Molecular Diagnostics: Personalizing Personalized Medicine

Jeffrey M. Perkel

Thirteen years after Roche launched the industry with a test for HIV load based on transcript abundance, molecular diagnostics is in full flower. A $3.3 billion market growing at 17 percent annually, the field includes assays for disease predisposition, screening, diagnosis, prognosis, monitoring, and predicting treatment efficacy, using markers ranging from SNPs to methylcytosine, messenger RNA to microRNA. Bringing digital power to traditional analog medicine, the field "is absolutely going to revolutionize health care," says Harry Glorikian, managing partner at Scientia Advisors. "I believe it with every fiber in my being."




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)